What is nodular-keloidal scleroderma?

Dermatology

Volumn 207, Issue 2, 2003, Pages 130-132

  Labandeira, Javier ^a,b   Leon Mateos A ^a   Suarez Penaranda J M ^a   Garea, M T ^a   Toribio, J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CEFUROXIME; CLOBETASOL PROPIONATE; DERMATOLOGICAL AGENT; DOXYCYCLINE; FIBRONECTIN; PENICILLAMINE; PENICILLIN G; PREDNISONE; STAZONOL; TENASCIN; UNCLASSIFIED DRUG;

CLINICAL FEATURE; DISEASE ASSOCIATION; EDITORIAL; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KELOID; KELOIDAL SCLERODERMA; NODULAR SCLERODERMA; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRURITUS; PUVA; SCLERODERMA; SKIN BIOPSY;

FIBROSIS; HUMANS; KELOID; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0042508789     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071780     Document Type: Editorial

References (42)

1. Addison T: On the keloid of Alibert and untrue keloid. Trans Med Chir Soc Lond 1854;37:27-47.
2. Unna PG: Die Histopathologie der Hautkrankheiten. Berlin, Hirschwald, 1894, p 1119.
3. Thibierge G: La pratique dermatologique. Paris, Masson, 1904, p 241.
4. Dubreuilh W: Fibromes miliaires: sclerodermie consëcutive. Ann Dermatol Syphilol 1906;7:569-572.
5. Lipschütz B: Knotenförmige Hautverdickungen bei Sklerodaktylie. Dermatol Wochenschr 1913;57:851-857.
6. Korting GW: Über keloidartige Sklerodermie nebst Bemerkungen über das etagenmässig differente Verhalten von einigen sklerodermischen Krankheitszuständen. Arch Dermatol Syphilis 1954;198:306-318.
7. Cabré BJ, Landes E: Ein Beitrag zur nodulären Sklerodermie (keloidähnliche Sklerodermie Unna). Z Hautkr 1960;28:359-364.
8. James WD, Berger TG, Butler DF, Tuffanelli DL: Nodular (keloidal) scleroderma. J Am Acad Dermatol 1984;11:1111-1114.
9. Kubo M, Tamaki T, Fujimoto M, Kikuchi K, Tamaki K: Keloidlike morphea. Acta Derm Venereol (Stockh) 1996;77:90-91.
10. Perez-Wilson J, Pujol RM, Alejo M, Geli C, de Moragas JM: Nodular (keloidal) scleroderma. Int J Dermatol 1992;31:422-423.
11. Krell JM, Solomon AR, Glavey CM, Lawley TJ: Nodular scleroderma. J Am Acad Dermatol 1995;32:343-345.
12. Burge SM, Mortimer PS, Ryan TJ: Pseudokeloidal scleroderma. Br J Dermatol 1985;113:99.
13. Wollina U, Looks A, Lange D: Extracorporeal photochemotherapy in nodular scleroderma. Br J Dermatol 1998;139:559-560.
14. Chevrant-Breton J, Le Breton M, Mignard MH: Sclérodermie nodulaire: un cas; cited by Perez-Wilson et al. [10].
15. Mizutani H, Taniguchi H, Sakakura T, Shimizu M: Nodular scleroderma: Focally increased tenascin expression differing from that in the surrounding scleroderma skin. J Dermatol 1995;22:267-271.
16. Yamamoto T, Furuse Y, Katayama I, Nishioka K: Nodular scleroderma in a worker using a silica-containing abrasive. J Dermatol 1994;21:751-754.
17. Sasaki T, Denpo K, Ono H, Nakajima H: Nodular scleroderma in systemic sclerosis under D-penicillamine therapy. J Dermatol 1992;19:968-971.
18. Reitmann K: Über eine eigenartige, der Skle-rodermie nahestehende Affektion. Arch Dermatol Syphilis 1908;92:417-424.
19. Bruhns C: Über Knotenbildungen bei Sklerodermie. Arch Dermatol Syphilis 1921;129:178-183.
20. Fletcher H: Case of sclerodermia and sclerodactylia. Proc R Soc Med 1921;14:40-41.
21. Dimitrova J, Molcho L, Rueva C, Pramatarov K: Nodular scleroderma. Z Haukr 1980;55:435-483.
22. Butler J, Laymon CW: Nodular diffuse scleroderma. Arch Dermatol 1937;35:919-931.
23. Stefanato CM, Gorkiewicz-Petkow A, Jarzabek-Chorzelska M, Jablonska S, Chorzelski T: Morphea with high titer of fibronectin antibodies. Int J Dermatol 1992;31:190-192.
24. Cantwell AR Jr, Rowe L, Kelso DW: Nodular scleroderma and pleomorphic acid-fast bacteria. Arch Dermatol 1980;116:1283-1290.
25. Akintewe TA, Alabi GO: Scleroderma presenting with multiple keloids. Br Med J 1985;291:448-449.
26. Bettley FR, Seville RH: Nodular scleroderma. Proc R Soc Med 1951;44:573-575.
27. Hsu S, Lee MW, Carlton S, Kramer EM: Nodular morphea in a linear pattern. Int J Dermatol 1999;38:529-530.
28. Jablonska S: Scleroderma and Pseudoscleroderma, ed 2, English. Warsaw, Polish Medical Publishers, 1975, pp 59-60, 277-303.
29. Micalizzi C, Parodi A, Rebora A: Morphea with nodular lesions. Br J Dermatol 1994;131:298-300.
30. Memmesheimer A; cited by Cabré and Landes [7].
31. Kobayashi KA, Lui H, Prendiville JS: Solitary morphea profunda in a 5-year-old girl: Case report and review of the literature. Pediatr Dermatol 1991;8:292-295.
32. Bonino MV, Bianchi C, Bianchi O, Garcia-Garcia A: Post-traumatic nodular scleroderma. Med Cutan Ibero Lat Am 1983;11:329-332.
33. Yamamoto T, Sakashita S, Sawada Y, Katayama I, Nishioka K: Possible role of epidermal growth factor in the lesional skin of nodular morphea. Acta Derm Venereol (Stockh) 1998; 78:312-313.
34. Nicolas J, Moutot H: Sclérodermie en plaques, forme mixte, lardacée et tubéreuse: traitement thyroïdien, amélioration rapide. Lyon Méd 1911;117:1458-1460.
35. Labandeira J, León-Mateos A, Suärez-Peñaranda JM, Garea MT, Toribio J: Polymorphic fibrosing reaction mimicking keloidal scleroderma but without associated classic scleroderma. Dermatology 2003;207:204-205.
36. Winkelmann RK: Localized cutaneous scleroderma. Semin Dermatol 1985;4:90.
37. Jimbow K, Kobayashi H, Ishii M, Oyanagi A, Ooshima A: Scar and keloid like lesions in progeria. Arch Dermatol 1988;124:1261-1266.
38. Nagata H, Ueki H, Moriguchi T: Fibronectin: Localization in normal human skin, granulation tissue, hypertrophic scar, mature scar, progressive systemic sclerotic skin, and other fibrosing dermatoses. Arch Dermatol 1985;121:995-999.
39. Birembaut P, Cahuzac P, Delhomme H, Caron Y, Labat-Robert J, Robert L, Kalis B: Distribution of fibronectin in the skin of patients with scleroderma. Ann Dermatol Vénéréol 1982;109:933-937.
40. Dalkowski A, Schuppan D, Orfanos CE, Zouboulis CC: Increased expression of tenascin C by keloids in vivo and in vitro. Br J Dermatol 1999;141:50-56.
41. Seyger MM, van den Hoogen FH, van Vlijmen-Willems IM, van de Kerkhof PC, de Jong EM: Localized and systemic scleroderma show different histological responses to methotrexate therapy. J Pathol 2001;193:511-516.
42. Hashimoto K: Over-expression of tenascin in scleroderma skin. Mie Med J 1991;41:31-39.